Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Regulation of estrogenic and nuclear factor κB functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells

Abstract

The natural polyamines -putrescine, spermidine, and spermine- are essential for cell growth and differentiation. Polyamines are involved in several gene regulatory functions, although their mechanism(s) of action has not been elucidated. We investigated the role of polyamines in the function of NF-κB and estrogen receptor-α (ERα), two transcription factors implicated in breast cancer cell proliferation and cell survival, using MCF-7 breast cancer cells. We found that spermine facilitated the binding of ERα and NF-κB to estrogen response element (ERE)- and NF-κB response element (NRE), respectively, and enhanced ERα-mediated transcriptional activation in transient transfection experiments. We also found that the association of the co-regulatory protein CBP/p300 with ERα and NF-κB was increased by spermine treatment of MCF-7 cells. Spermine also increased the nuclear translocation of NF-κB compared to the control. In contrast, treatment of MCF-7 cells with polyamine analogs, BE-3-4-3 and BE-3-3-3, resulted in transcriptional inhibition of both ERE- and NRE-driven reporter plasmids. In addition, polyamine analogs inhibited the association of ERα and NF-κB with CBP/p300 and were unable to facilitate nuclear translocation of NF-κB. APO-BRDU assay demonstrated that polyamine analogs induced apoptosis, with a loss of the anti-apoptotic protein Bcl-2. These data show a gene regulatory function of polyamines involving transcriptional activation of ERα and NF-κB, potentially leading to the up-regulation of genes involved in breast cancer cell proliferation. Our results with BE-3-4-3 and BE-3-3-3 suggest that down-regulation of ERα- and NF-κB-regulated genes is a possible mechanism for the action of polyamine analogs in inducing apoptosis of breast cancer cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12

Similar content being viewed by others

References

  • Abraham SE, Lobo S, Yaciuk P, Wang HG, Moran E . 1993 Oncogene 8: 1639–1647

  • Baldwin Jr AS . 1996 Annu. Rev. Immunol. 14: 649–681

  • Baeurle PA, Baltimore D . 1996 Cell 87: 13–20

  • Beg AA, Baltimore D . 1996 Science 274: 782–784

  • Berchtold CM, Tamez P, Kensler TW, Casero Jr RA . 1998 J. Cell Physiol. 174: 380–386

  • Berger SL . 1999 Curr. Opin. Cell Biol. 11: 336–341

  • Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS . 1986 Proc. Natl. Acad. Sci. USA 83: 2496–2500

  • Biswas DK, Cruz AP, Gansberger E, Pardee AB . 2000 Proc. Natl. Acad. Sci. USA 97: 8542–8547

  • Boland MP, O'Neill LA . 1998 J Biol Chem. 273: 15494–15500

  • Bradford MM . 1976 Anal. Biochem. 72: 248–254

  • Bryans M, Harley E, Gilmour SK . 1996 Biochem. Biophys. Res. Commun. 226: 618–625

  • Canizares F, Salinas J, de las Heras M, Diaz J, Tovar I, Martinez P, Penafiel R . 1999 Clin. Cancer Res. 5: 2035–2041

  • Carlotti F, Dower SK, Qwarnstrom EE . 2000 J. Biol. Chem. 275: 41028–41034

  • Casero Jr RA, Celano P, Ervin SJ, Porter CW, Bergeron RJ, Libby PR . 1989 Cancer Res. 49: 3829–3833

  • Casero RA, Pegg AE . 1993 FASEB J. 7: 653–661

  • Celano P, Baylin SB, Casero Jr RA . 1989 J. Biol. Chem. 264: 8922–8927

  • Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin Jr AS . 2000 Oncogene 19: 1123–1131

  • Cohen SS . 1998 A Guide to the Polyamines Oxford University Press: New York

    Google Scholar 

  • Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW . 1997 Proc. Natl. Acad. Sci. USA 94: 10057–10062

  • Cusack Jr JC, Liu R, Baldwin Jr AS . 2000 Cancer Res. 60: 2323–2330

  • Davidson NE, Mank AR, Prestigiacomo LJ, Bergeron RJ, Casero Jr RA . 1993 Cancer Res. 53: 2071–2075

  • Davidson NE, Hahm HA, McCloskey DE, Woster PM, Casero Jr RA . 1999 Endoc. Relat. Cancer 6: 69–73

  • Davis RH, Morris DR, Coffino P . 1992 Microbiol. Rev. 56: 280–290

  • Delzenne NM, Kok N, Deloyer P, Dandrifosse G . 2000 J. Nutr. 130: 2456–2460

  • Doerre S, Corley RB . 1999 J. Immunol. 163: 269–277

  • Desiderio MA, Dansi P, Tacchini L, Bernelli-Zazzera A . 1999 FEBS Lett. 455: 149–153

  • Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C, Safe S . 1999 J. Biol. Chem. 274: 32099–32107

  • Faaland CA, Laskin JD, Thomas TJ . 1995 Cell Growth Differ. 6: 115–121

  • Faaland CA, Thomas TJ, Mian S, Shirahata A, Gallo MA, Thomas T . 2000 Biochem. Cell Biol. 78: 415–426

  • Feuerstein BG, Pattabiraman N, Marton LJ . 1990 Nucleic Acids Res. 18: 1271–1282

  • Gabrielson EW, Pegg AE, Casero Jr RA . 1999 Clin. Cancer Res. 5: 1638–1641

  • Galien R, Garcia T . 1997 Nucleic Acids Res. 25: 2424–2429

  • Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T . 1997 Proc. Natl. Acad. Sci. USA 94: 2927–2932

  • Grumont RJ, Rourke IJ, Gerondakis S . 1999 Genes Dev. 13: 400–411

  • Guttridge D, Albanese CC, Reuther Y, Pestell RG, Baldwin Jr AS . 1999 Mol. Cell Biol. 19: 5785–5799

  • Ha HC, Woster PM, Yager JD, Casero Jr RA . 1997 Proc. Natl. Acad. Sci. USA 94: 11557–11562

  • Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy BR, Kurokawa R, Brown M . 1996 Proc. Natl. Acad. Sci. USA 93: 11540–11545

  • Harhaj EW, Sun SC . 1999 Mol. Cell Biol. 19: 7088–7095

  • Hibshoosh H, Johnson M, Weinstein IB . 1991 Oncogene 6: 739–743

  • Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M . 1999 Mol. Cell Biol. 19: 2690–2698

  • Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto S, Tung L . 1996 Mol. Endocrinol. 10: 1167–1177

  • Hu RH, Pegg AE . 1997 Biochem. J. 328: 307–316

  • Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A, Bhalla K . 1997 Breast Cancer Res. Treat. 42: 73–81

  • Igarashi K, Koga K, He Y, Shimogori T, Ekimoto H, Kashiwagi K, Shirahata A . 1995 Cancer Res. 55: 2615–2619

  • Igarashi K, Kashiwagi K . 2000 Biochem Biophys Res Commun 271: 559–564

  • Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF . 1996 Cell 86: 787–798

  • Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS . 1996 Mol. Endocrinol. 10: 119–131

  • Kee BL, Arias J, Montminy MR . 1996 J. Biol. Chem. 271: 2373–2375

  • Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, Russo J, Sonenshein GE . 2000 Carcinogenesis 21: 871–879

  • Klinge CM, Silver BF, Driscoll MD, Sathya G, Bambara RA, Hilf R . 1997 J. Biol. Chem. 272: 31465–31474

  • Kramer DL, Fogel-Petrovic M, Diegelman P, Cooley JM, Bernacki RJ, McManis JS, Bergeron RJ, Porter CW . 1997 Cancer Res. 57: 5521–5527

  • Krappmann D, Scheidereit C . 1997 Immunobiology 198: 3–13

  • Kuo MH, Allis CD . 1998 Bioessays 20: 615–626

  • Kurebayashi S, Miyashita Y, Hirose T, Kasayama S, Akira S, Kishimoto T . 1997 J. Steroid Biochem. Mol. Biol. 60: 11–17

  • Leveque J, Bansard JY, Watier E, Catros-Quemener V, Havouis R, Moulinoux JP, Grall JY, Seiler N . 1999 Anticancer Res. 19: 2275–2279

  • Leveque J, Foucher F, Bansard JY, Havouis R, Grall JY, Moulinoux JP . 2000 Breast Cancer Res Treat. 60: 99–105

  • Manni A, Grove R, Kunselman S, Aldaz M . 1995 Cancer Lett. 92: 49–57

  • MacGregor JI, Jordan VC . 1998 Pharmacol. Rev. 50: 151–196

  • MacKichan ML, Logeat F, Israel A . 1996 J. Biol. Chem. 271: 6084–6091

  • Manni A, Grove R, Kunselman S, Aldaz M . 1995 Cancer Lett. 92: 49–57

  • Marton LJ, Pegg AE . 1995 Annu. Rev. Pharmacol. Toxicol. 35: 55–91

  • Matsushita H, Morishita R, Nata T, Aoki M, Nakagami H, Taniyama Y, Yamamoto K, Higaki J, Yasufumi K, Ogihara T . 2000 Circ. Res. 86: 974–978

  • Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin Jr AS . 1997 Science 278: 1812–1815

  • McCloskey DE, Casero Jr RA, Woster PM, Davidson NE . 1995 Cancer Res. 55: 3233–3236

  • McCloskey DE, Yang J, Woster PM, Davidson NE, Casero Jr RA . 1996 Clin. Cancer Res. 2: 441–446

  • McKay LI, Cidlowski JA . 1998 Mol. Endocrinol. 12: 45–56

  • McKenna NJ, Lanz RB, O'Malley BW . 1999 Endocr. Rev. 20: 321–344

  • Munoz E, Courtois G, Veschambre V, Jalinot P, Israel A . 1994 J. Virol. 68: 8035–8044

  • Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ, Sledge Jr GW . 1997 Mol. Cell Biol. 17: 3629–3639

  • Newton TR, Patel NM, Bhat-Nakshatri P, Stauss CR, Goulet Jr RJ, Nakshatri H . 1999 J. Biol. Chem. 274: 18827–18835

  • O'Brien MJ, O'Keane JC, Zauber A, Gottlieb LS, Winawer SJ . 1992 Cancer 70: 1317–1327

  • O'Brien TG, Megosh LC, Gilliard G, Soler AP . 1997 Cancer Res. 57: 2630–2637

  • Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y . 1996 Cell 87: 953–959

  • Panagiotidis CA, Artandi S, Calame K, Silverstein SJ . 1995 Nucleic Acids Res. 23: 1800–1809

  • Pegg AE, McCann PP . 1982 Am. J. Physiol. 243: C212–C221

  • Pera PJ, Kramer DL, Sufrin JR, Porter CW . 1986 Cancer Res. 46: 1148–1154

  • Porter CW, Bergeron RJ . 1988 Adv. Exp. Med. Biol. 250: 677–690

  • Porter CW, Pegg AE, Ganis B, Madhubala R, Bergeron RJ . 1990 Biochem. J. 268: 207–212

  • Porter CW, Ganis B, Rustum Y, Wrzosek C, Kramer DL, Bergeron RJ . 1994 Cancer Res. 54:: 5917–5924

  • Rauch BH, Weber A, Braun M, Zimmermann N, Schror K . 2000 FEBS Lett. 481: 3–7

  • Rayet B, Gelinas C . 1999 Oncogene 18: 6938–6947

  • Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aime-Sempe C, Bodrug S, Kitada S, Hanada M . 1996 J. Cell Biochem. 60: 23–32

  • Rouet-Benzineb P, Gontero B, Dreyfus P, Lafuma C . 2000 J. Mol Cell Cardiol. 32: 1767–1778

  • Ryan KM, Ernst MK, Rice NR, Vousden KH . 2000 Nature 404: 892–897

  • Scalabrino G, Lorenzini EC . 1991 Mol. Cell Endocrinol. 7: 37–56

  • Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP . 1999 J. Biol. Chem. 274: 33551–33556

  • Schorr K, Li M, Krajewski S, Reed JC, Furth PA . 1999 J. Mammary Gland Biol. Neoplasia 4: 153–164

  • Shah N, Thomas T, Shirahata A, Sigal LH, Thomas TJ . 1999 Biochemistry 38: 14763–14774

  • Sharma A, Glaves D, Porter CW, Raghavan D, Bernacki RJ . 1997 Clin. Cancer Res. 3: 1239–1244

  • Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK, Collins T . 1999 Mol. Cell Biol. 19: 6367–6978

  • Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE . 1997 J. Clin. Invest. 100: 2952–2960

  • Siebenlist U, Franzoso G, Brown K . 1994 Annu. Rev. Cell Biol. 10: 405–455

  • Smith MK, Trempus CS, Gilmour SK . 1998 Carcinogenesis 19: 1409–1415

  • Stein B, Yang MX . 1995 Mol. Cell Biol. 15: 4971–4979

  • Tabib A, Bachrach U . 1994 Biochem. Biophys. Res. Commun. 202: 720–727

  • Tabib A, Bachrach U . 1999 Int. J. Biochem. Cell. Biol. 31: 1289–1295

  • Tabor CW, Tabor H . 1984 Annu. Rev. Biochem. 53: 749–790

  • Thomas TJ, Faaland CA, Adhikarakunnathu S, Watkins LF, Thomas T . 1998 Breast Cancer Res. Treat. 47: 181–193

  • Thomas T, Gallo MA, Klinge CM, Thomas TJ . 1995 J. Steroid Biochem. Mol. Biol. 54: 89–99

  • Thomas T, Kulkarni GD, Gallo MA, Greenfield N, Shirahata A, Lewis JS, Thomas TJ . 1997 Nucleic Acids Res. 25: 2396–2402

  • Thomas T, Shah N, Klinge CM, Faaland CA, Adikarakunnathu S, Gallo MA, Thomas TJ . 1999 J. Mol. Endocrinol. 22: 131–139

  • Thomas T, Thomas TJ . 1993 Breast Cancer Res. Treat. 29: 189–201

  • Thomas T, Thomas TJ . 2001 Cellu. Mol. Life Sci. 58: 244–258

  • Tremblay A, Tremblay GB, Labrie F, Giguere V . 1999 Mol. Cell 3: 513–519

  • Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, Haegeman G . 1999 J. Biol. Chem. 274: 32091–32098

  • Wadgaonkar R, Phelps KM, Haque Z, Williams AJ., Silverman ES, Collins T . 1999 J. Biol. Chem. 274: 1879–1882

  • Wang CY, Cusack Jr JC, Liu R, Baldwin Jr AS . 1999 Nat. Med. 5: 412–417

  • Wang CY, Mayo MW, Baldwin Jr AS . 1996 Science 274: 784–787

  • Watanabe S, Kusama-Eguchi K, Kobayashi H, Igarashi K . 1991 J. Biol. Chem. 266: 20803–20809

  • Zhang GJ, Kimijima I, Onda M, Kanno M, Sato H, Watanabe T, Tsuchiya A, Abe R, Takenoshita S . 1999 Clin. Cancer Res. 5: 2971–2977

  • Zhang GJ, Kimijima I, Tsuchiya A, Abe R . 1998 Oncol. Rep. 5: 1211–1216

  • Zhong H, Voll RE, Ghosh S . 1998 Mol. Cell 1: 661–671

  • Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C . 1999 Genes Dev. 13: 382–387

Download references

Acknowledgements

This work was supported by Public Health Service grants CA 42439, CA 73058, CA 80163 (T Thomas and TJ Thomas), DK 53220 (CM Kinge), Outstanding Breast Cancer Research Grant Awards from the NJ State Commission on Cancer Research (T Thomas and TJ Thomas), and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (A Shirahata).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shah, N., Thomas, T., Lewis, J. et al. Regulation of estrogenic and nuclear factor κB functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells. Oncogene 20, 1715–1729 (2001). https://doi.org/10.1038/sj.onc.1204247

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204247

Keywords

This article is cited by

Search

Quick links